Hye-Kyung Kim
Director/Board Member at ENZYCHEM LIFESCIENCES CORPORATION
Net worth: 89 251 $ as of 2024-03-30
Profile
Hye-Kyung Kim is currently the Chief Executive Officer at Bridget Lifesciences Corp., Vice Chairman at ENZYCHEM LIFESCIENCES Corp., and Vice Chairman at Konex Association.
She completed her undergraduate degree at Ewha Womans University and her graduate degree at Korea National Open University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-17 | 63,810 ( 0.08% ) | 89 251 $ | 2024-03-30 |
Hye-Kyung Kim active positions
Companies | Position | Start |
---|---|---|
ENZYCHEM LIFESCIENCES CORPORATION | Director/Board Member | 2012-06-30 |
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Chief Executive Officer | 2002-12-31 |
Konex Association | Director/Board Member | 2013-12-31 |
Training of Hye-Kyung Kim
Ewha Womans University | Undergraduate Degree |
Korea National Open University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
ENZYCHEM LIFESCIENCES Corp. | |
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Finance |
Konex Association |
- Stock Market
- Insiders
- Hye-Kyung Kim